For instance, patients with high circulating levels of IGF1 have an increased risk of developing ovarian cancer before the age of 55 [36],[37], and high levels of IGF1 mRNA and protein are further linked to disease progression [38]. Here, IGF1 is linked to ovarian carcinoma.